GIMBE - News Metodologiche - Pagina 5

Home

News Metodologiche - Pagina 5

ONLINE IL SITO GIMBE SULL'EMERGENZA COVID-19

News Metodologiche

GIMBE: Eventi, progetti, pubblicazioni e altre attività istituzionali della Fondazione GIMBE
Metodologiche: articoli pertinenti le aree del know-how GIMBE, pubblicati nei top-six journals*
Cliniche: articoli di ricerca clinica primaria e secondaria pubblicati nei top-six journals*
Sanità: notizie dalla sanità italiana
Eventi: congressi, conferenze, workshop nazionali e internazionali relativi alle aree del know-how GIMBE

*N Engl J Med, Lancet, Ann Intern Med, JAMA, BMJ, PLos Med

21 settembre 2019

Flawed evidence underpins approval of new cancer drugs

BMJ 2019;366:l5399

How precision medicine and screening with big data could increase overdiagnosis

BMJ 2019;366:l5270

19 settembre 2019

Creating a Learning Health System through Rapid-Cycle, Randomized Testing

10 settembre 2019

The use of validated and nonvalidated surrogate endpoints in two European Medicines Agency expedited approval pathways: A cross-sectional study of products authorised 2011–2018

PLoS Med 2019;16(9): e1002873.

6 settembre 2019

Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance

PLoS Med 2019;16(9): e1002915.

3 settembre 2019

Realizing Shared Decision-making in Practice

JAMA 2019;322:811-812

Harms From Uninformative Clinical Trials

JAMA 2019;322:813-814

Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods From the Clinical Guidelines Committee of the American College of Physicians

Ann Intern Med 2019;171:354-361.

29 agosto 2019

Promoting Pediatric Drug Research and Labeling - Outcomes of Legislation

N Engl J Med 2019;381:875-881

20 agosto 2019

Methods for Development of the European Commission Initiative on Breast Cancer Guidelines: Recommendations in the Era of Guideline Transparency

Ann Intern Med 2019;171:273-280

3

4

5

6

7

Pagina aggiornata il 28/04/2024